23andMe's Struggle: From Success to Survival
DNA-testing giant faces financial and privacy challenges
Three years ago, DNA-testing company 23andMe was thriving with a share price surpassing even Apple's.
Known for offering detailed reports on ancestry and genetics, it attracted millions, including celebrities like Snoop Dogg and Oprah Winfrey.
However, the firm's share value has now plummeted from $321 to under $5, and it recently avoided delisting from the stock market.
23andMe, co-founded by Anne Wojcicki, has faced significant hurdles.
Critiques, like Professor Dimitris Andriosopoulos from Strathclyde University, point to the company's lack of a sustainable business model and delayed profitability from drug research initiatives.
The DNA database held by 23andMe is a major concern, given the sensitivity of genetic data.
Carissa Veliz, author of 'Privacy is Power', highlights the privacy risks not only to users but also to their relatives.
Despite assurances from the company about data protection compliance, the possibility of changes in ownership and security breaches remain troubling, echoing past incidents like last year's hack.
Anne Wojcicki remains at the helm after a board resignation and is reportedly committed to taking the company private.
Yet, speculation persists about a potential sale, especially with competitors like Ancestry watching closely.
The situation underscores broader issues in data privacy, with calls for stricter regulations on personal data trade to ensure greater protection for individuals.
Known for offering detailed reports on ancestry and genetics, it attracted millions, including celebrities like Snoop Dogg and Oprah Winfrey.
However, the firm's share value has now plummeted from $321 to under $5, and it recently avoided delisting from the stock market.
23andMe, co-founded by Anne Wojcicki, has faced significant hurdles.
Critiques, like Professor Dimitris Andriosopoulos from Strathclyde University, point to the company's lack of a sustainable business model and delayed profitability from drug research initiatives.
The DNA database held by 23andMe is a major concern, given the sensitivity of genetic data.
Carissa Veliz, author of 'Privacy is Power', highlights the privacy risks not only to users but also to their relatives.
Despite assurances from the company about data protection compliance, the possibility of changes in ownership and security breaches remain troubling, echoing past incidents like last year's hack.
Anne Wojcicki remains at the helm after a board resignation and is reportedly committed to taking the company private.
Yet, speculation persists about a potential sale, especially with competitors like Ancestry watching closely.
The situation underscores broader issues in data privacy, with calls for stricter regulations on personal data trade to ensure greater protection for individuals.
